Recipient cytokine genotypes for TNF-α and IL-10 and the minor histocompatibility antigens HY and CD31 codon 125 are not associated with occurrence or severity of acute GvHD in unrelated cord blood transplantation: A retrospective analysis

Transplantation

Volumn 74, Issue 8, 2002, Pages 1167-1175

  Kögler, Gesine ^a   Middleton, Peter G ^a   Wilke, Martina ^a   Rocha, Vanderson ^a   Esendam, Bennie ^a   Enczmann, Jürgen ^a   Wernet, Peter ^a   Gluckman, Eliane ^a   Querol, Sergio ^a   Lecchi, Lucilla ^a   Goulmy, Els ^a   Dickinson, Anne M ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; HLA ANTIGEN; INTERLEUKIN 10; MINOR HISTOCOMPATIBILITY ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ADOLESCENT; ADULT; ALLELE; ARTICLE; BONE MARROW TRANSPLANTATION; CELL HETEROGENEITY; CHILD; CODON; CORRELATION FUNCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; EXON; FEMALE; GENETIC RISK; GENOTYPE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECIPIENT;

EID: 17644429770     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200210270-00019     Document Type: Article

References (35)

1. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339(22): 1565.
2. Locatelli F, Rocha V, Chastang C, et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia: Eurocord-Cord Blood Transplant Group. Blood 1999; 93(11): 3662.
3. Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97(10): 2962.
4. Cohen SB, Perez Cruz I, Fallen P, et al. Analysis of the cytokine production by cord and adult blood. Hum Immunol 1999; 60(4): 331.
5. Groux H, O'Garra A, Bigler M, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389(6652): 737.
6. Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24(1): 1.
7. Middleton PG, Taylor PR, Jackson G, et al. Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood 1998; 92(10): 3943.
8. Turner D, Grant SC, Yonan N, et al. Cytokine gene polymorphism and heart transplant rejection. Transplantation 1997; 64(5): 776.
9. Mayer FR, Messer G, Knabe W, et al. High response to TNFα secretion in vivo in patients undergoing BMT may be associated with the 308 bp TNF-α-gene enhancer polymorphism. Bone Marrow Transplant 1996; 17: 101.
10. Holler E, Roncarolo MG, Hintermeier-Knabe R, et al. Low incidence of transplant related complications in patients with high spontaneous cellular IL-10 production prior to conditioning: Evidence for a protective role of IL-10 in allogeneic BMT. Bone Marrow Transplant 1995; 15: S59.
11. Cavet J, Middleton PG, Segall M, et al. Recipient tumor necrosis factor α and interleukin 10 gene polymorphisms associated with early mortality and acute graft versus host disease severity in HLA-matched sibling bone marrow transplants. Blood 1999; 94(11): 1.
12. Goulmy E, Schipper R, Pool J, et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996; 334(5): 281.
13. Tseng L, Lin M, Hansen J, et al. Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-host disease after allogeneic marrow transplantation. Blood 1999; 94(8): 2911.
14. Gallardo D, Arostegui JI, Balas A, et al. Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation. Br J Haematol 2001; 114(4): 931.
15. Socié G, Loiseau P, Tamouza R, et al. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation 2001; 72(4): 699.
16. Behar E, Chao NJ, Hiraki DD, et al. Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease. N Engl J Med 1996; 334(5): 286.
17. Nichols WC, Antin JH, Lunetta KL, et al. Polymorphism of adhesion molecule CD31 is not a significant risk factor for graft-versus-host disease. Blood 1996; 88(12): 4429.
18. Balduini C, Noris P, Giorgiani G, et al. Incompatibility for CD31 and human platelet antigens and acute graft-host disease after bone marrow transplantation. Br J Haematol 1999; 106(3): 723.
19. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graftversus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18(4): 295.
20. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man: A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69(2): 204.
21. Kogler G, Callejas J, Hakenberg P, et al. Hematopoietic transplant potential of unrelated cord blood: Critical issues. J Hematother 1996; 5(2): 105.
22. Wilke M, Pool J, den Haan JM, et al. Genomic identification of the minor histocompatibility antigen HA-1 locus by allele-specific PCR. Tissue Antigens 1998; 52(4): 312.
23. den Haan JM, Meadows LM, Wang W, et al. The minor histocompatibility antigen HA-1: A diallelic gene with a single amino acid polymorphism. Science 1998; 279(5353): 1054.
24. Eskdale J, Gallagher G, Verweij CL, et al. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A 1998; 95(16): 9465.
25. Sorg RV, Kogler G, Wernet P. Identification of cord blood dendritic cells as an immature CD11c-population. Blood 1999; 93(7): 2302.
26. Cohen S, Wang X, Dickinson A. Can cord blood cells support the cytokine storm in GvHD? Cytokine Growth Factor Rev 2000; 11(3): 185.
27. Bogunia-Kubik K, Perez-Cruz I, Fallen P, et al. Cord blood lymphocytes have a low frequency of cytokine producing T cells due to a high threshold for activation. Immunol Lett 2000; 72(3): 145.
28. Bacchetta R, Bigler M, Touraine JL, et al. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med 1994; 179(2): 493.
29. Gluckman E, Rocha V, Chevret S. Related and unrelated cord blood transplantation. In: Cohen SBA, Gluckman E, Rubinstein P, et al, eds. Cord Blood Characteristics: Role in Stem Cell Transplantation. London, Martin Dunitz Ltd, 2000.
30. Gluckman E, Rocha V, Boyer Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors: Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997; 337(6): 373.
31. Koegler G, Wilke M, Middleton P, et al. Cytokine gene polymorphisms of the recipient influences the development of acute GvHD in HLA mismatched cord blood transplants [abstract]. Blood 1999; 94: 639a.
32. Koegler G, Wilke M, Middleton P, et al. Cytokine gene polymorphism of the recipient influences the development of acute graft versus host disease in HLA mismatched cord blood transplants [abstract]. Bone Marrow Transplant 2000; 25: S4.
33. Cullup H, Dickinson A, Jackson G, et al. Donors interleukin 1 receptor antagonist genotype associated with acute graft-versus-host disease in human leucocyte antigen-matched sibling allogeneic transplants. Br J Haematol 2001; 113(3): 807.
34. Cavet J, Dickinson A, Norden J, et al. Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood 2001; 98(5): 1594.
35. Dickinson AM, Cavet J, Cullup H, et al. GvHD risk assessment in hematopoietic stem cell transplantation: Role of cytokine gene polymorphisms and an in vitro human skin explant model. Hum Immunol 2001; 62(11): 1266.